Isolation and Characterization of Moringa Olifera Gum: A Novel Sustained Release Polymer
If one were to imagine the ideal drug delivery system, two prerequisites would be required. First, it would be a single dose for the duration of treatment, whether it will be for days or weeks, as with infection, or for the lifetime of the patient, as in hypertension or diabetis. Second, it should deliver the active entity directly to the site of action, thereby minimising or eliminating side effects. This may necessitate delivery to specific receptors or to localization to cells or to specific areas of the body. In the past decade great interest got generated on replacing conventional administration of drugs by novel delivery systems which would release effective quantities from a protected supply at a controlled rate over a long period of time. Ideally a drug to provide desired therapeutic action should arrive rapidly at the site of action (receptor) in optimum concentration, remain there for desired time, spare other sites and get removed from the site. One of the interesting results of pharmaceutical research is the fact that absorption rate of a drug can be decreased by reducing its rate of release from the dosage form. The products so formulated are designed as sustained action, sustained release, delayed action, prolonged action, depot, respiratory, retarded release and timed release medication. In order to control the release of drug from its dosage form, an effective sustained release polymer is essential. Though, there are several sustained release polymers available in the market, there is continuous need to develop sustained release polymers which are safe and inexpensive. The aim of the work was to isolate and characterize the Moringa olifera gum as novel sustained release polymer.
Keywords: Isolation, Sustained release, Moringa Olifera gum
2. Aulton ME, Wells TI, Pharmaceutics. The Science of Dosage Form Design, London, England, Churchill Livingstone, 1988, 133-135.
3. Indian Pharmacopoeia, New Delhi, Ministry of Health and Family Welfare, Government of India, Controller of Publications, Vol II, 2007, 662-665.
4. Lachman L, Liberman HA, Kanig JL, The Theory And Practice Of Industrial Pharmacy,3rd Edition, Mumbai, India, Varghese Publishing House, 1999,297-299.
5. Kokate CK, Purohit AP. Gokhale SB, Pharmacognosy Volume –I, June 2010, 45 th Edition.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).